Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
Gilead Sciences, Inc. announced on 9 May that it will acquire privately held XinThera, Inc. for an undisclosed...






